Luca Arecco

1.1k total citations · 1 hit paper
48 papers, 516 citations indexed

About

Luca Arecco is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luca Arecco has authored 48 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 18 papers in Public Health, Environmental and Occupational Health and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luca Arecco's work include Reproductive Biology and Fertility (16 papers), Cancer Risks and Factors (14 papers) and Advanced Breast Cancer Therapies (8 papers). Luca Arecco is often cited by papers focused on Reproductive Biology and Fertility (16 papers), Cancer Risks and Factors (14 papers) and Advanced Breast Cancer Therapies (8 papers). Luca Arecco collaborates with scholars based in Italy, Belgium and United States. Luca Arecco's co-authors include Matteo Lambertini, Andrea Boutros, Francesco Spagnolo, Claudia Massarotti, Enrica T. Tanda, Stefano Spinaci, Lucia Del Mastro, Maria Grazia Razeti, Marco Bruzzone and Marcello Ceppi and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Clinical Cancer Research.

In The Last Decade

Luca Arecco

44 papers receiving 511 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The treatment of advanced melanoma: Current approaches and new challenges

2024 50 citations Andrea Boutros, Marco Ferrari et al. Critical Reviews in Oncology/Hematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Arecco Italy	15	280	224	157	84	68	48	516
Ivana Rizzuto United Kingdom	10	150 0.5×	91 0.4×	173 1.1×	141 1.7×	44 0.6×	24	457
Hatem A. Azim Italy	7	329 1.2×	296 1.3×	171 1.1×	70 0.8×	40 0.6×	14	538
Alessia D’Alonzo Italy	9	136 0.5×	175 0.8×	149 0.9×	61 0.7×	26 0.4×	23	341
Alessia Romito Italy	11	118 0.4×	78 0.3×	209 1.3×	98 1.2×	31 0.5×	19	394
S. Giraudi Italy	11	278 1.0×	548 2.4×	470 3.0×	129 1.5×	44 0.6×	24	716
Diana P. English United States	14	275 1.0×	50 0.2×	165 1.1×	183 2.2×	112 1.6×	31	676
Karishma Mehra United States	10	93 0.3×	120 0.5×	336 2.1×	134 1.6×	53 0.8×	11	578
Hanne Stensheim Norway	8	574 2.0×	172 0.8×	110 0.7×	68 0.8×	27 0.4×	12	682
Monika Sobočan Slovenia	13	62 0.2×	120 0.5×	55 0.4×	102 1.2×	26 0.4×	47	423
Kathrine S Rallis United Kingdom	10	166 0.6×	44 0.2×	78 0.5×	147 1.8×	64 0.9×	31	458

Countries citing papers authored by Luca Arecco

Since Specialization

Citations

This map shows the geographic impact of Luca Arecco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Arecco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Arecco more than expected).

Fields of papers citing papers by Luca Arecco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Arecco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Arecco. The network helps show where Luca Arecco may publish in the future.

Co-authorship network of co-authors of Luca Arecco

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Arecco. A scholar is included among the top collaborators of Luca Arecco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Arecco. Luca Arecco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agostinetto, Elisa, et al.. (2026). Abstract GS1-03: Adjuvant aromatase inhibitor or tamoxifen in patients with hormone receptor-positive/HER2-positive early breast cancer: An exploratory analysis from the ALTTO (BIG 2-06) trial. Clinical Cancer Research. 32(4_Supplement). GS1–3. 1 indexed citations

Spinaci, Stefano, et al.. (2025). Treatments of Interest in Male Breast Cancer: An Umbrella Review. Journal of Personalized Medicine. 15(2). 66–66. 1 indexed citations

Arecco, Luca, Eva Blondeaux, Marco Bruzzone, et al.. (2025). Prognostic implications of risk definitions from the monarchE and NATALEE trials. JNCI Journal of the National Cancer Institute. 117(6). 1198–1208. 3 indexed citations

Arecco, Luca, et al.. (2025). Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies. Human Reproduction. 40(8). 1452–1466. 2 indexed citations

Arecco, Luca, Elisa Agostinetto, Maria Alice Franzoi, et al.. (2025). Extended adjuvant endocrine therapy in early breast cancer: finding the individual balance. ESMO Open. 10(5). 105057–105057. 3 indexed citations

Arecco, Luca, Gabriella Gentile, Matteo Lambertini, et al.. (2025). Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives. Current Opinion in Oncology. 37(6). 552–561. 1 indexed citations

Gerosa, R., Gabriella Gentile, Luca Arecco, et al.. (2025). Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge. ESMO Open. 10(9). 105758–105758. 1 indexed citations

Boutros, Andrea, Marco Ferrari, Giulia Massaro, et al.. (2024). The treatment of advanced melanoma: Current approaches and new challenges. Critical Reviews in Oncology/Hematology. 196. 104276–104276. 50 indexed citations breakdown →

Arecco, Luca, Roberto Borea, Stefano Spinaci, et al.. (2024). Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer. Expert Review of Anticancer Therapy. 24(9). 803–817. 2 indexed citations

10.

Lambertini, Matteo, et al.. (2023). Advances in the Management of Menopausal Symptoms, Fertility Preservation, and Bone Health for Women With Breast Cancer on Endocrine Therapy. American Society of Clinical Oncology Educational Book. 43(43). e390442–e390442. 15 indexed citations

11.

Boutros, Andrea, Enrica T. Tanda, Luca Arecco, et al.. (2023). Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma. Journal of Geriatric Oncology. 15(2). 101640–101640. 2 indexed citations

12.

Boutros, Andrea, Enrica T. Tanda, Fabio Catalano, et al.. (2023). Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis. European Journal of Cancer. 188. 64–79. 24 indexed citations

13.

Agostinetto, Elisa, Luca Arecco, & Evandro de Azambuja. (2023). Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely?. Oncology and Therapy. 12(1). 19–29. 6 indexed citations

14.

Cardinali, Bárbara, Roberta Tasso, Simona Coco, et al.. (2022). Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer. International Journal of Molecular Sciences. 23(11). 6320–6320. 7 indexed citations

15.

Arecco, Luca, Eva Blondeaux, Marco Bruzzone, et al.. (2022). Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis. Human Reproduction. 37(5). 954–968. 61 indexed citations

16.

Arecco, Luca, Valentino Martelli, Andrea Boutros, et al.. (2021). How to Protect Ovarian Function before and during Chemotherapy?. Journal of Clinical Medicine. 10(18). 4192–4192. 20 indexed citations

17.

Martelli, Valentino, Maria Maddalena Latocca, Marta Perachino, et al.. (2021). Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women. Breast Cancer Targets and Therapy. Volume 13. 341–351. 11 indexed citations

18.

Boutros, Andrea, Marco Bruzzone, Enrica T. Tanda, et al.. (2021). 1687P Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomized controlled trials: A systematic review and meta-analysis. Annals of Oncology. 32. S1180–S1181. 1 indexed citations

19.

Parisi, Francesca, Maria Grazia Razeti, Eva Blondeaux, et al.. (2020). Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer. Clinical Medicine Insights Oncology. 14. 2282627560–2282627560. 6 indexed citations

20.

Arecco, Luca, Marta Perachino, Maria Maddalena Latocca, et al.. (2020). Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients. Breast Cancer Basic and Clinical Research. 14. 2222511683–2222511683. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact